Home/Filings/4/0001438133-22-000087
4//SEC Filing

BLICKENSTAFF KIM D 4

Accession 0001438133-22-000087

CIK 0001438133other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 7:14 PM ET

Size

20.6 KB

Accession

0001438133-22-000087

Insider Transaction Report

Form 4
Period: 2022-05-17
BLICKENSTAFF KIM D
DirectorPRESIDENT AND CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2022-05-17$9.00/sh+6,560$59,0408,452 total
  • Exercise/Conversion

    Common Stock

    2022-05-18+2,20510,657 total
  • Exercise/Conversion

    Common Stock

    2022-05-17$73.73/sh+13,562$999,872215,952 total(indirect: See Footnote)
  • Exercise/Conversion

    Stock Option

    2022-05-17$9.00/sh+6,560$59,0400 total
    Exercise: $9.00Common Stock (6,560 underlying)
  • Exercise/Conversion

    Warrant

    2022-05-17$73.73/sh+13,562$999,8720 total(indirect: See Footnote)
    Exercise: $73.73From: 2022-05-17Common Stock (13,562 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2022-05-18+2,2050 total
    Common Stock (2,205 underlying)
  • Sale

    Common Stock

    2022-05-17$92.91/sh10,762$999,897205,190 total(indirect: See Footnote)
Footnotes (9)
  • [F1]Represents shares of common stock received upon exercise of a stock option award.
  • [F2]The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.
  • [F3]The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
  • [F4]The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
  • [F5]The expiration date for these options is 10 years from the date of grant.
  • [F6]The expiration dates for these warrants are May 25, 2022 (2,712 shares), and July 3, 2022 (10,850 shares).
  • [F7]Awarded on May 18, 2021 pursuant to the 2013 Plan, as amended, and the agreements related thereto.
  • [F8]Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company.
  • [F9]Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

Issuer

TANDEM DIABETES CARE INC

CIK 0001438133

Entity typeother

Related Parties

1
  • filerCIK 0001238913

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 7:14 PM ET
Size
20.6 KB